CCRM

Commercializing Living Therapies with CCRM

Science EN ↓ Odcinki: 28

Hear from academic and industry experts sharing insider insights, information and trend forecasts for the cell and gene therapy industry. “Commercializing Living Therapies with CCRM” is brought to you by CCRM, a leader in developing, manufacturing and commercializing regenerative medicine-based technologies, and cell and gene therapies. Questions / comments? email: podcast@ccrm.ca.

Koniecznie odwiedź stronę podcastu i wesprzyj twórcę: www.ccrm.ca

Autor

CCRM

Kategoria

Science

Strona podcastu

www.ccrm.ca

Ostatni odcinek

15 paź 2026

Gdzie słuchać?

Podcasty w aplikacji Replaio Radio Już wkrótce

Podcasty trafią do aplikacji już wkrótce. Zainstaluj teraz i jako pierwszy zobacz nowe podejście do podcastów

Zainstaluj za darmo Android prawie 10 mln pobrań · ocena 4,8 iOS niedługo

Odcinki

Moving from A to B 14.02.2022 31:10

Manufacturing and supply chain issues in cell and gene therapies. Featuring: Dr. Anthony Davies, Founder and CEO, Dark Horse Consulting Rob Jones, Vice President, Global Bioservices, Cryoport Systems It’s no secret that supply chain and manufacturing are crucial to the cell and gene therapy industry, but now the whole world seems to be paying attention. This sudden interest has made Anthony...

Chaperoning innovation through the valley of death 14.01.2022 26:32

The business of regenerative medicine and investment. Featuring: Dr. Cynthia Lavoie, President and Chief Investment Officer, CCRM Enterprises Geoff MacKay, President and CEO, AVROBIO Dr. Lavoie and Mr. MacKay share what brought them to regenerative medicine in the first place, why investors are bullish about the field, and which trends they have an eye on as they are looking to the future. Jo...

The importance of educating the public about cell and gene therapies 14.12.2021 24:43

How can the regenerative medicine community create broader societal awareness? Featuring: Dr. Janet Rossant, President and Scientific Director, Gairdner Foundation Dr. Phil Vanek, Chief Technology Officer, Gamma Biosciences Drs. Rossant and Vanek discuss public awareness of cell and gene therapies, the importance of improving it, and how confusing and misleading claims made about unapproved stem...